secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001193125-25-284609
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis closes $770M 0% convertible notes offering, repurchases $200M of 2026 notes
--------------------------------------------------------------------------------

- Issued $770M aggregate principal of 0.00% Convertible Senior Notes due 2030 (including full greenshoe), net proceeds ~$751.2M.
- Used ~$267.6M of net proceeds to repurchase $200M of existing 2026 convertible notes via concurrent transactions.
- Remaining proceeds for further repurchases of 2026 notes and general corporate purposes.
- Initial conversion rate: 10.1932 shares/$1,000, conversion price ~$98.10 (35% premium over Nov 12 close of $72.67).
- Notes mature Dec 1, 2030, no regular interest, redeemable after Dec 6, 2028 if stock ≥130% of conversion price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000119312525284609/0001193125-25-284609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000119312525284609/d31230d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-284609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer